United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$112Mraised across 3 rounds since 2019, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Monograph CapitalLead
Canaan
Morningside Group
F-Prime Capital
Osage University Partners
Mission BioCapital
Lumira Ventures
BioInnovation Capital
Mass General Brigham VenturesReported by Lumira VenturesSEC filing: $23M sold, first sale Dec 2025
Source recordedSEC filing: $31M sold, first sale Feb 2024
CanaanLeadF-Prime CapitalLeadReported by FinSMEs
From Nocion Therapeutics's own website: 1 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Nocion Therapeutics's investors include Canaan, F-Prime Capital, Mission BioCapital, Monograph Capital and Arkin Bio Capital, and 7 more on record. Monograph Capital led its latest round.
Nocion Therapeutics has raised $112M across 3 rounds since 2019.
Nocion Therapeutics's most recent round was a Series B of $23M in Jan 2026, led by Monograph Capital.
Nocion Therapeutics's largest round on record is $62M (Series B), in Mar 2024.
Nocion Therapeutics's first round on record, in Apr 2019, was backed by Canaan, F-Prime Capital and Partners HealthCare Innovation and 1 others.
Nocion Therapeutics's latest named round is a Series B, in Jan 2026.
Nocion Therapeutics is based in the United States.
Canaan led the Series A in 2019; Monograph Capital led the Series B in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
